Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
13.78
+0.53 (4.00%)
Aug 13, 2025, 4:00 PM - Market closed
Carlsmed Employees
Carlsmed had 89 employees as of December 31, 2024.
Employees
89
Change
n/a
Growth
n/a
Revenue / Employee
$362,562
Profits / Employee
-$288,933
Market Cap
365.39M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 89 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CARL News
- 13 days ago - Carlsmed's aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures - GlobeNewsWire
- 17 days ago - Carlsmed's aprevo® Powers First Personalized Cervical Spine Surgery - GlobeNewsWire
- 21 days ago - Carlsmed: Spine Play Does Not Have My Backing Yet - Seeking Alpha
- 22 days ago - Carlsmed Announces Pricing of Initial Public Offering - Business Wire
- 22 days ago - Carlsmed Announces Launch of Initial Public Offering - Business Wire
- 26 days ago - U.S. IPO Weekly Recap: Mining Companies Lead The Calendar As More Sizable IPOs Submit Initial Filings - Seeking Alpha
- 6 weeks ago - Carlsmed Files For IPO On High Growth And High Operating Losses - Seeking Alpha
- 6 weeks ago - Spine surgery-focused medtech Carlsmed files for a $100 million IPO - Renaissance Capital